57.1 USD
+0.11 (+0.19%)
57.1 USD
0 (0%)
TECH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TECH was profitable.
In the past year TECH had a positive cash flow from operations.
Each year in the past 5 years TECH has been profitable.
In the past 5 years TECH always reported a positive cash flow from operatings.
1.2 Ratios
TECH has a better Return On Assets (3.04%) than 73.68% of its industry peers.
With a decent Return On Equity value of 3.91%, TECH is doing good in the industry, outperforming 73.68% of the companies in the same industry.
With an excellent Return On Invested Capital value of 9.33%, TECH belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 13.99%.
The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROIC | 9.33% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
TECH has a better Profit Margin (6.32%) than 73.68% of its industry peers.
In the last couple of years the Profit Margin of TECH has declined.
The Operating Margin of TECH (22.13%) is better than 91.23% of its industry peers.
In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
The Gross Margin of TECH (66.83%) is better than 89.47% of its industry peers.
TECH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TECH is destroying value.
Compared to 1 year ago, TECH has less shares outstanding
The number of shares outstanding for TECH has been increased compared to 5 years ago.
Compared to 1 year ago, TECH has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 11.18 indicates that TECH is not in any danger for bankruptcy at the moment.
TECH has a Altman-Z score of 11.18. This is amongst the best in the industry. TECH outperforms 94.74% of its industry peers.
TECH has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
The Debt to FCF ratio of TECH (1.34) is better than 89.47% of its industry peers.
TECH has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
TECH has a Debt to Equity ratio of 0.15. This is comparable to the rest of the industry: TECH outperforms 59.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Altman-Z | 11.18 |
ROIC/WACC0.9
WACC10.39%
2.3 Liquidity
TECH has a Current Ratio of 4.22. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
TECH's Current ratio of 4.22 is fine compared to the rest of the industry. TECH outperforms 68.42% of its industry peers.
TECH has a Quick Ratio of 2.81. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
TECH's Quick ratio of 2.81 is fine compared to the rest of the industry. TECH outperforms 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
TECH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
The Revenue for TECH has decreased by -16.00% in the past year. This is quite bad
TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
3.2 Future
Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.76%
EPS Next 2Y7.83%
EPS Next 3Y11.09%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.59 indicates a quite expensive valuation of TECH.
Based on the Price/Earnings ratio, TECH is valued a bit cheaper than 71.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.26. TECH is around the same levels.
Based on the Price/Forward Earnings ratio of 25.44, the valuation of TECH can be described as expensive.
Based on the Price/Forward Earnings ratio, TECH is valued a bit cheaper than 77.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, TECH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.59 | ||
| Fwd PE | 25.44 |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than TECH, based on the Enterprise Value to EBITDA ratio.
63.16% of the companies in the same industry are more expensive than TECH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.71 | ||
| EV/EBITDA | 24.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)6.21
PEG (5Y)2.63
EPS Next 2Y7.83%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
With a yearly dividend of 0.53%, TECH is not a good candidate for dividend investing.
TECH's Dividend Yield is rather good when compared to the industry average which is at 0.09. TECH pays more dividend than 92.98% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, TECH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has paid a dividend for at least 10 years, which is a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
TECH pays out 65.26% of its income as dividend. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y7.83%
EPS Next 3Y11.09%
57.1
+0.11 (+0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners107%
Inst Owner Change7.13%
Ins Owners0.25%
Ins Owner Change3.89%
Market Cap8.90B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target70.79 (23.98%)
Short Float %5.95%
Short Ratio4.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)4.28%
PT rev (3m)4.86%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-6.24%
EPS NY rev (1m)-1.06%
EPS NY rev (3m)-1.44%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)-3.77%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.59 | ||
| Fwd PE | 25.44 | ||
| P/S | 7.31 | ||
| P/FCF | 39.71 | ||
| P/OCF | 35.41 | ||
| P/B | 4.53 | ||
| P/tB | 13.97 | ||
| EV/EBITDA | 24.12 |
EPS(TTM)1.93
EY3.38%
EPS(NY)2.24
Fwd EY3.93%
FCF(TTM)1.44
FCFY2.52%
OCF(TTM)1.61
OCFY2.82%
SpS7.81
BVpS12.62
TBVpS4.09
PEG (NY)6.21
PEG (5Y)2.63
Graham Number23.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROCE | 11.3% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.93% | ||
| ROICexgc | 24.48% | ||
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% | ||
| FCFM | 18.41% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 25.63% | ||
| Cap/Sales | 2.24% | ||
| Interest Coverage | 14.5 | ||
| Cash Conversion | 66.94% | ||
| Profit Quality | 291.58% | ||
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 11.18 |
F-Score5
WACC10.39%
ROIC/WACC0.9
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y4.76%
EPS Next 2Y7.83%
EPS Next 3Y11.09%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.24%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status for TECH stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
How profitable is BIO-TECHNE CORP (TECH) stock?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
How financially healthy is BIO-TECHNE CORP?
The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 4.76% in the next year.